Financials

News Discussions Technicals Forecast Seasonals

SYNACT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. It also performs clinical development in order to secure proof-of-concept such as clinical relevance. The company was founded by Søren Nielsen on April 12, 2016 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

SYNACT has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company